Equities research analysts expect Kindred Healthcare, Inc. (NYSE:KND) to post sales of $1.47 billion for the current quarter, Zacks reports. Two analysts have made estimates for Kindred Healthcare’s earnings, with the highest sales estimate coming in at $1.49 billion and the lowest estimate coming in at $1.45 billion. Kindred Healthcare posted sales of $1.75 billion in the same quarter last year, which would indicate a negative year-over-year growth rate of 16%. The firm is scheduled to announce its next quarterly earnings report on Monday, February 26th.
On average, analysts expect that Kindred Healthcare will report full-year sales of $1.47 billion for the current year, with estimates ranging from $5.98 billion to $6.04 billion. For the next financial year, analysts expect that the company will post sales of $6.13 billion per share. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side analysts that cover Kindred Healthcare.
Kindred Healthcare (NYSE:KND) last issued its quarterly earnings results on Monday, November 6th. The health services provider reported ($0.11) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.19) by $0.08. The company had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.44 billion. Kindred Healthcare had a positive return on equity of 2.29% and a negative net margin of 8.06%. The business’s revenue for the quarter was down 5.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.05 EPS.
A number of equities analysts have weighed in on the stock. Zacks Investment Research cut shares of Kindred Healthcare from a “hold” rating to a “sell” rating in a research report on Wednesday, August 30th. Deutsche Bank AG reissued a “hold” rating and issued a $9.00 target price (down previously from $10.00) on shares of Kindred Healthcare in a report on Monday, September 18th. BidaskClub lowered shares of Kindred Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, July 31st. Mizuho reiterated a “neutral” rating and set a $7.50 price objective (down previously from $8.00) on shares of Kindred Healthcare in a research note on Tuesday, October 10th. Finally, Royal Bank Of Canada lowered their price objective on shares of Kindred Healthcare from $9.00 to $7.50 and set a “sector perform” rating on the stock in a research note on Thursday, September 21st. Three analysts have rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $9.17.
Kindred Healthcare (NYSE KND) traded down $0.10 during mid-day trading on Friday, hitting $7.60. The stock had a trading volume of 709,550 shares, compared to its average volume of 1,298,315. Kindred Healthcare has a 1-year low of $5.50 and a 1-year high of $11.90. The firm has a market cap of $660.69, a P/E ratio of 38.00 and a beta of 1.12. The company has a current ratio of 1.55, a quick ratio of 1.53 and a debt-to-equity ratio of 6.22.
Institutional investors and hedge funds have recently made changes to their positions in the stock. JPMorgan Chase & Co. raised its holdings in Kindred Healthcare by 149.4% in the 2nd quarter. JPMorgan Chase & Co. now owns 2,104,618 shares of the health services provider’s stock worth $24,518,000 after acquiring an additional 1,260,753 shares during the period. Bank of New York Mellon Corp increased its holdings in shares of Kindred Healthcare by 2.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,488,869 shares of the health services provider’s stock worth $17,345,000 after purchasing an additional 34,553 shares during the period. Smith Graham & Co. Investment Advisors LP increased its holdings in shares of Kindred Healthcare by 39.6% during the 3rd quarter. Smith Graham & Co. Investment Advisors LP now owns 1,238,980 shares of the health services provider’s stock worth $8,425,000 after purchasing an additional 351,280 shares during the period. Teachers Advisors LLC increased its holdings in shares of Kindred Healthcare by 8.1% during the 2nd quarter. Teachers Advisors LLC now owns 162,452 shares of the health services provider’s stock worth $1,893,000 after purchasing an additional 12,132 shares during the period. Finally, BlackRock Inc. increased its holdings in shares of Kindred Healthcare by 0.3% during the 2nd quarter. BlackRock Inc. now owns 10,808,864 shares of the health services provider’s stock worth $125,923,000 after purchasing an additional 29,673 shares during the period. Hedge funds and other institutional investors own 88.62% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This report was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another domain, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2017/12/05/kindred-healthcare-inc-knd-expected-to-announce-quarterly-sales-of-1-47-billion.html.
Kindred Healthcare Company Profile
Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.
Get a free copy of the Zacks research report on Kindred Healthcare (KND)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.